Short Term
Mean Reversion
Very Strong
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Very Strong
Momentum
Price
Neutral
Earnings
Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Telephone
1.833.462.8482
Address
Suite 220 28159 Avenue Stanford Valencia, CA 91355
Description
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.34 - 6.27
Trade Value (12mth)
AU$253,516.00
1 week
2.04%
1 month
23.97%
YTD
-27.36%
1 year
-43.61%
All time high
104.14
EPS 3 yr Growth
-31.900%
EBITDA Margin
-242.00%
Operating Cashflow
-$57m
Free Cash Flow Return
-44.40%
ROIC
-41.30%
Interest Coverage
-106.20
Quick Ratio
7.50
Shares on Issue (Fully Dilluted)
128m
HALO Sector
Healthcare
Next Company Report Date
20-Feb-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.28
Date | Announcements |
---|---|
12 July 24 |
AVITA Medical to Announce Second Quarter 2024 Results
×
AVITA Medical to Announce Second Quarter 2024 Results |
10 July 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
10 July 24 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
09 July 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
05 July 24 |
Statement of CDIs on issue - AVH
×
Statement of CDIs on issue - AVH |
03 July 24 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
02 July 24 |
AVITA Medical Appoints Nicole Kelsey as Chief Legal Officer
×
AVITA Medical Appoints Nicole Kelsey as Chief Legal Officer |
14 June 24 |
Updated Insider Trading & Securities Dealing Policy
×
Updated Insider Trading & Securities Dealing Policy |
14 June 24 |
Change of Director's Interest Notice - Cary Vance
×
Change of Director's Interest Notice - Cary Vance |
14 June 24 |
Change of Director's Interest Notice - James Corbett
×
Change of Director's Interest Notice - James Corbett |
14 June 24 |
Change of Director's Interest Notice - Jan Stern Reed
×
Change of Director's Interest Notice - Jan Stern Reed |
14 June 24 |
Change of Director's Interest Notice - Jeremy Curnock Cook
×
Change of Director's Interest Notice - Jeremy Curnock Cook |
14 June 24 |
Change of Director's Interest Notice - Louis Panaccio
×
Change of Director's Interest Notice - Louis Panaccio |
14 June 24 |
Change of Director's Interest Notice - Robert McNamara
×
Change of Director's Interest Notice - Robert McNamara |
14 June 24 |
Change of Director's Interest Notice - Suzanne Crowe
×
Change of Director's Interest Notice - Suzanne Crowe |
13 June 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
13 June 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
13 June 24 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
07 June 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
07 June 24 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
06 June 24 |
AVITA Medical Announces First Case Using RECELL GO
×
AVITA Medical Announces First Case Using RECELL GO |
06 June 24 |
Results of 2024 Annual Meeting of Stockholders
×
Results of 2024 Annual Meeting of Stockholders |
06 June 24 |
Statement of CDIs on issue - AVH
×
Statement of CDIs on issue - AVH |
05 June 24 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
05 June 24 |
2024 Annual Meeting of Stockholders Presentation
×
2024 Annual Meeting of Stockholders Presentation |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.